dshps and dsips CMS to end federal match for states' Medicaid funding requests What Health Plans Should Know

But does the science support the extraordinary claims

Safety Considerations Usually well-tolerated in research studies

A clinician can help identify any underlying conditions and, if needed, recommend targeted treatments

Healthcare practitioners who compound, prescribe or supply unapproved peptide products have been warned by the Therapeutic Goods Administration (TGA) to comply with regulatory requirements and professional practice standards

International Journal of Molecular Sciences, 20(21), 5407

Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use